Mutual regulation of PTEN and P-REX2a in normal and cancer cells
正常细胞和癌细胞中 PTEN 和 P-REX2a 的相互调节
基本信息
- 批准号:8025381
- 负责人:
- 金额:$ 33.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-01-01 至 2015-12-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressApoptosisAttenuatedBindingBiochemistryBrainCancer BiologyCatalytic DomainCell Migration Inhibition functionCell ProliferationCellsCellular biologyComplexDevelopmentDiseaseEnzymesEquilibriumFibroblastsGeneticGoalsGuanine Nucleotide Exchange FactorsGuanosine TriphosphateHumanIn VitroKineticsLipidsMalignant NeoplasmsMass Spectrum AnalysisMediatingMediator of activation proteinMolecularMonomeric GTP-Binding ProteinsMusMutateMutationNeoplasm MetastasisNeuronsNormal CellOncogenicOutputPH DomainPIK3CA genePTEN genePathway interactionsPhenotypePhosphatidylinositolsPhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPhysiologicalProteinsProto-Oncogene Proteins c-aktReceptor ActivationRegulationResearchRoleSecond Messenger SystemsSignal PathwaySignal TransductionTailTestingTimeTumor Suppressor Proteinsbasecancer cellcell growthcell motilityexpectationin vitro activityinhibitor/antagonistinterestmigrationmouse modelmutantneoplastic celloverexpressionreceptorresearch studysecond messengertheoriestherapeutic targettumor
项目摘要
DESCRIPTION (provided by applicant): PTEN is a tumor suppressor that is deregulated in a large number of human cancers to activate the oncogenic phosphoinositide-3 kinase (PI3K) pathway. Inactivation of PTEN leads to multiple cancer related phenotypes including enhanced cellular proliferation, migration, and survival. We have recently determined that PREX2 is an inhibitor of PTEN phosphatase activity. PREX2 is over expressed in human cancers with wild type PTEN. Moreover, PREX2 is often over expressed in cancers that harbor mutations in the PIK3CA gene, which encodes the catalytic subunit of PI3K. We have shown that mutant PIK3CA and PREX2 can stimulate cell growth in vitro, and that reduced expression of PREX2 inhibits tumor cell growth in a setting of wild type PTEN. PREX2 encodes an enzyme that catalyzes the loading of GTP onto the small GTPase RAC1 and is a mediator of cell migration and normal development in the brain. We propose that PTEN is likely to function to inhibit migration through PREX2; thus, PREX2 and PTEN are candidate mutual inhibitors. This application will use a combination of biochemistry, cell biology, mouse genetics, and cancer biology to address the following goals: 1) determine the molecular mechanism through which PREX2 inhibits PTEN phosphatase activity in vitro and activates the PI3K pathway in cells, 2) define the genetic relationships between PTEN and PREX2 in fibroblasts and the brain, 3) assess the contribution of PREX2 to PIK3CA mediated tumor formation, 4) define the mechanism through which PTEN inhibits PREX2-induced cell migration.
PUBLIC HEALTH RELEVANCE: The PI3K pathway causes the formation of cancer. Analysis of human tumors has shown that it is one of the most frequently activated pathways in many forms of human malignancy. In many cases, pathway activation in cancer cannot be explained. Here we will define an important mechanism of PTEN inhibition via PREX2 that appears to be a common mechanism for activating the PI3K pathway. PREX2 represents a target for therapeutic inhibition of the PI3K pathway in disease.
描述(由申请人提供):PTEN是一种肿瘤抑制因子,其在大量人类癌症中失调以激活致癌性磷酸肌醇-3激酶(PI 3 K)途径。PTEN的失活导致多种癌症相关表型,包括增强的细胞增殖、迁移和存活。我们最近确定PREX 2是PTEN磷酸酶活性的抑制剂。PREX 2在具有野生型PTEN的人类癌症中过表达。此外,PREX 2通常在PIK 3CA基因中含有突变的癌症中过度表达,PIK 3CA基因编码PI 3 K的催化亚基。我们已经表明突变体PIK 3CA和PREX 2可以在体外刺激细胞生长,并且PREX 2的表达减少在野生型PTEN的情况下抑制肿瘤细胞生长。PREX 2编码一种酶,催化GTP加载到小GTP酶RAC 1上,并且是大脑中细胞迁移和正常发育的介导剂。我们认为,PTEN可能通过PREX 2发挥抑制迁移的作用,因此,PREX 2和PTEN是候选的相互抑制剂。该应用程序将使用生物化学,细胞生物学,小鼠遗传学和癌症生物学的组合,以解决以下目标:1)确定PREX 2在体外抑制PTEN磷酸酶活性并激活细胞中PI 3 K通路的分子机制,2)确定成纤维细胞和脑中PTEN和PREX 2之间的遗传关系,3)评估PREX 2对PIK 3CA介导的肿瘤形成的贡献,4)定义PTEN抑制PREX 2诱导的细胞迁移的机制。
公共卫生相关性:PI 3 K通路导致癌症的形成。对人类肿瘤的分析表明,它是许多形式的人类恶性肿瘤中最频繁激活的途径之一。在许多情况下,癌症中的通路激活无法解释。在这里,我们将定义通过PREX 2抑制PTEN的重要机制,PREX 2似乎是激活PI 3 K通路的常见机制。PREX 2代表疾病中PI 3 K通路的治疗性抑制的靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ramon E Parsons其他文献
Ramon E Parsons的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ramon E Parsons', 18)}}的其他基金
THE TISCH CANCER INSTITUTE - CANCER CENTER SUPPORT GRANT
蒂施癌症研究所 - 癌症中心支持拨款
- 批准号:
10674487 - 财政年份:2015
- 资助金额:
$ 33.3万 - 项目类别:
THE TISCH CANCER INSTITUTE - CANCER CENTER SUPPORT GRANT
蒂施癌症研究所 - 癌症中心支持拨款
- 批准号:
10229103 - 财政年份:2015
- 资助金额:
$ 33.3万 - 项目类别:
The Tisch Cancer Institute - Cancer Center Support Grant
蒂施癌症研究所 - 癌症中心支持补助金
- 批准号:
9753966 - 财政年份:2015
- 资助金额:
$ 33.3万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 33.3万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 33.3万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 33.3万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 33.3万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 33.3万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 33.3万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 33.3万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 33.3万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 33.3万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 33.3万 - 项目类别:
Research Grant